Human Longevity, a tech-driven genomics company founded and led by pioneering geneticist J. Craig Venter, has acquired San Diego’s Cypher Genomics for an undisclosed amount.
The acquisition will add Cypher’s human genomic interpretation software solutions to Human Longevity’s offerings.
Cypher has 14 employees, all of whom will join Human Longevity, including Cypher CEO and co-founder Ashley Van Zeeland. Van Zeeland has been appointed head of Human Longevity's Pediatric Business, according to a press release.
"Cypher Genomics has created important automated and scalable genome interpretation technology informed by additional expertise in genetics and biology that we believe will be invaluable to (Human Longevity's) business,” Venter said in a statement. “The Cypher team, led by Dr. Van Zeeland, is a very impressive group of scientists who will be crucial in augmenting HLI's already unparalleled and comprehensive genomic database business.”
Cypher has developed and marketed Mantis, proprietary software which provides comprehensive and unbiased interpretation of genomic sequencing data enabling customers to rapidly uncover clinically significant variants, according to the news release. The company has also developed Coral, a biomarker discovery service.
Cypher has a number of industry collaborators for these products, including Celgene, Illumina and Sequenom. The local firm also has academic partnerships with Scripps Translational Science Instutute, the University of Pennsylvania and Clinic for Special Children.
Venter and two co-founders launched Human Longevity last year, with the goal of creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data. The company aims to develop and use large-scale computing and machine learning to make discoveries intended to revolutionize the practice of medicine.